Literature DB >> 12556455

Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function.

Daniel E Michele1, Kevin P Campbell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12556455     DOI： 10.1074/jbc.R200031200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  139 in total

Review 1.  Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies.

Authors:  C A Collins; J E Morgan
Journal:  Int J Exp Pathol       Date:  2003-08       Impact factor: 1.925

2.  Cytoskeleton-plasma membrane-cell wall continuum in plants. Emerging links revisited.

Authors:  Frantisek Baluska; Jozef Samaj; Przemyslaw Wojtaszek; Dieter Volkmann; Diedrik Menzel
Journal:  Plant Physiol       Date:  2003-10       Impact factor: 8.340

Review 3.  Regulation of matrix biology by matrix metalloproteinases.

Authors:  Joni D Mott; Zena Werb
Journal:  Curr Opin Cell Biol       Date:  2004-10       Impact factor: 8.382

4.  Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection.

Authors:  Yuji Hara; Motoi Kanagawa; Stefan Kunz; Takako Yoshida-Moriguchi; Jakob S Satz; Yvonne M Kobayashi; Zihan Zhu; Steven J Burden; Michael B A Oldstone; Kevin P Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

5.  Mdm muscular dystrophy: interactions with calpain 3 and a novel functional role for titin's N2A domain.

Authors:  Kimberly A Huebsch; Elena Kudryashova; Christine M Wooley; Roger B Sher; Kevin L Seburn; Melissa J Spencer; Gregory A Cox
Journal:  Hum Mol Genet       Date:  2005-08-22       Impact factor: 6.150

6.  Absence of post-phosphoryl modification in dystroglycanopathy mouse models and wild-type tissues expressing non-laminin binding form of α-dystroglycan.

Authors:  Atsushi Kuga; Motoi Kanagawa; Atsushi Sudo; Yiumo Michael Chan; Michiko Tajiri; Hiroshi Manya; Yamato Kikkawa; Motoyoshi Nomizu; Kazuhiro Kobayashi; Tamao Endo; Qi L Lu; Yoshinao Wada; Tatsushi Toda
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

7.  Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Kunil K Raval; Ran Tao; Brent E White; Willem J De Lange; Chad H Koonce; Junying Yu; Priya S Kishnani; James A Thomson; Deane F Mosher; John C Ralphe; Timothy J Kamp
Journal:  J Biol Chem       Date:  2014-12-08       Impact factor: 5.157

8.  Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality.

Authors:  Tobias Willer; Belén Prados; Juan Manuel Falcón-Pérez; Ingrid Renner-Müller; Gerhard K H Przemeck; Mark Lommel; Antonio Coloma; M Carmen Valero; Martin Hrabé de Angelis; Widmar Tanner; Eckhard Wolf; Sabine Strahl; Jesús Cruces
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

9.  Muscle-specific expression of LARGE restores neuromuscular transmission deficits in dystrophic LARGE(myd) mice.

Authors:  Jessica D Gumerson; Carol S Davis; Zhyldyz T Kabaeva; John M Hayes; Susan V Brooks; Daniel E Michele
Journal:  Hum Mol Genet       Date:  2012-12-06       Impact factor: 6.150

10.  Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts.

Authors:  Karen Fernandez; Yelda Serinagaoglu; Sue Hammond; Laura T Martin; Paul T Martin
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.